HER2 status predicts for upfront AI benefit: A TRANS-AIOG meta-analysis of 12,129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2

Thumbnail
View/Open
Publication Date
2017-07
ICR Author
Author
Bartlett, JMS
Ahmed, I
Regan, MM
Sestak, I
Mallon, EA
Dell'Orto, P
Thurlimann, B
Seynaeve, C
Putter, H
Van de Velde, CJH
Brookes, CL
Forbes, JF
Viale, G
Cuzick, J
Dowsett, M
Rea, DW
Inhibitor, TA
Type
Journal Article
Metadata
Show full item record
URL
https://repository.icr.ac.uk/handle/internal/1590
Collections
Licenseref URL
https://creativecommons.org/licenses/by/4.0
Version of record
Subject
Breast cancer
HER2
Prediction
Aromatase inhibitor
Meta-analysis
Research team
Endocrinology
Date accepted
2017-04-01
License start date
2017-07
Citation
EUROPEAN JOURNAL OF CANCER, 2017, 79 pp. 129 - 138